Antengene Announces Board Composition and Committee Roles

Antengene Corporation Limited (HK:6996) has released an update.

Antengene Corporation Limited, a biopharmaceutical company listed under stock code 6996, has announced the composition of its board of directors and the roles within its four Board committees. The board includes Executive Directors Dr. Jay Mei, who serves as Chairman and CEO, Mr. John F. Chin, and Mr. Donald Andrew Lung, alongside Independent Non-executive Directors Ms. Jing Qian, Mr. Sheng Tang, and Dr. Rafael Fonseca. Key committee positions and memberships were also detailed, highlighting the company’s governance structure.

For further insights into HK:6996 stock, check out TipRanks’ Stock Analysis page.